4Filing Date: Sep 9, 2026
Idexx Laboratories (IDXX)
Statement of Changes in Beneficial Ownership
View SEC Filing
ACC: 0000874716-26-000127
Total Value$1.42M
Trades3
Insiders1
Transaction Details
Kingsley Lawrence D
Director·Direct
Exercise · Acquire
Common Stock
Shares+2.20K
Price$114.17
Total Value$251.5K
Shares Owned After11.77K
Transaction DateSep 4, 2026
Kingsley Lawrence D
Director·Direct
Sell · Dispose
Common Stock
Shares-2.20K
Price$532.08
Total Value$1.17M
Shares Owned After9.57K
Transaction DateSep 4, 2026
Footnotes ▸
Represents the weighted average price of the shares sold ranging from a low of $531.88 to a high of $532.14 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Kingsley Lawrence D
Director·Direct
Exercise · Dispose
Non-Qualified Stock Option (right-to-buy)Derivative
Shares-2.20K
Price-
Total Value$0
Shares Owned After0
Transaction DateSep 4, 2026
Exercise Price$114.17
ExpiresNov 30, 2026
Footnotes ▸
Not applicable. | Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vested in one installment on May 3, 2017.
Post-Transaction Holdings
Kingsley Lawrence D · Director
| Security | Shares | Change |
|---|---|---|
| Common Stock | 11.77K | - |
| Non-Qualified Stock Option (right-to-buy) | 0 | -2.20K (-100.00%) |
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership ===
Document Type: 4
Period of Report: 2026-09-04
10b5-1 Pre-arranged Plan: No
--- Issuer ---
Name: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
--- Reporting Owner ---
Name: Kingsley Lawrence D
CIK: 0001301427
Role: Director
--- Non-Derivative Transactions ---
[Transaction #1]
Security: Common Stock
Date: 2026-09-04 | Code: M (Exercise of derivative)
Shares: +2,203 | Price: $114.17
Total Value: $251,516.51
Shares Owned After: 11,771 | Ownership: D (Direct)
[Transaction #2]
Security: Common Stock
Date: 2026-09-04 | Code: S (Open market sale)
Shares: -2,203 | Price: $532.08
Total Value: $1,172,177.97
Shares Owned After: 9,568 | Ownership: D (Direct)
Footnotes:
[F1] Represents the weighted average price of the shares sold ranging from a low of $531.88 to a high of $532.14 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
--- Derivative Transactions ---
[Transaction #1]
Security: Non-Qualified Stock Option (right-to-buy)
Date: 2026-09-04 | Code: M (Exercise of derivative)
Shares: -2,203
Exercise Price: $114.17
Exercisable: N/A | Expires: 2026-11-30
Shares Owned After: 0 | Ownership: D (Direct)
Footnotes:
[F3] Not applicable.
[F2] Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vested in one installment on May 3, 2017.
--- Footnotes (Complete Index) ---
F1: Represents the weighted average price of the shares sold ranging from a low of $531.88 to a high of $532.14 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
F2: Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vested in one installment on May 3, 2017.
F3: Not applicable.
--- Signature ---
/s/ /s/ Lily J. Lu, Attorney-in-Fact for Lawrence D. Kingsley (2026-09-09)